APA (7th ed.) Citation

Chen, J., Yang, F., Li, H., Pradhan, R., & Ortiz, S. (2026). Population PK–PD Modeling of Danicopan Add‐On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab. CPT: Pharmacometrics & Systems Pharmacology, 15(3), 1. https://doi.org/10.1002/psp4.70209

Chicago Style (17th ed.) Citation

Chen, Jun, Feng Yang, Hanbin Li, Rajendra Pradhan, and Stephan Ortiz. "Population PK–PD Modeling of Danicopan Add‐On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab." CPT: Pharmacometrics & Systems Pharmacology 15, no. 3 (2026): 1. https://doi.org/10.1002/psp4.70209.

MLA (9th ed.) Citation

Chen, Jun, et al. "Population PK–PD Modeling of Danicopan Add‐On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab." CPT: Pharmacometrics & Systems Pharmacology, vol. 15, no. 3, 2026, p. 1, https://doi.org/10.1002/psp4.70209.